Evidence map›Paper›PMID 19434080›Full record

ReviewNature reviews. Genetics2009

Maintaining the brain: insight into human neurodegeneration from Drosophila melanogaster mutants.

Derek Lessing, Nancy M Bonini

Abstract readReview
In one paragraph

Review in Nature reviews. Genetics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. International journal of molecular sciences · 2026
    Review
  3. A Landscape ofBiology · 2026
    Review
  4. Article
  5. ALife science alliance · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Identification of Tau Toxicity Modifiers in the Drosophila Eye.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  12. Article
  13. Article
  14. Prion disease modelled in Drosophila.Cell and tissue research · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Drosophila as a model to explore secondary injury cascades after traumatic brain injury.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021
    Review
  20. Review

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Derek LessingHoward Hughes Medical Institute, University of Pennsylvania, 306 Leidy Laboratories, 433 South University Avenue, Philadelphia, Pennsylvania 19104, USA.
Nancy M Bonini

Funding

POSTTRANSLATIONAL MODIFICATIONS OF ALPHA SYNUCLEINP01AG009215 · NIA · UNIVERSITY OF PENNSYLVANIA · PI LEE, VIRGINIA M-Y · 1990 to 2009
$14.1M
Molecular Genetic Analysis of NeurodegenerationR01NS043578 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI BONINI, NANCY M · 2003 to 2007
$1.3M
Howard Hughes Medical InstituteNIA NIH HHS P01 AG009215NINDS NIH HHS R01 NS043578
6 · The paper itself

Abstract

The fruitfly Drosophila melanogaster has enabled significant advances in neurodegenerative disease research, notably in the identification of genes that are required to maintain the structural integrity of the brain, defined by recessive mutations that cause adult onset neurodegeneration. Here, we survey these genes in the fly and classify them according to five key cell biological processes. Over half of these genes have counterparts in mice or humans that are also associated with neurodegeneration. Fly genetics continues to be instrumental in the analysis of degenerative disease, with notable recent advances in our understanding of several inherited disorders, Parkinson's disease, and the central role of mitochondria in neuronal maintenance.

Indexed as

AnimalsAnimals, Genetically ModifiedBrainDrosophila melanogasterDrosophila ProteinsHumansMutationNerve DegenerationNeurodegenerative DiseasesDrosophila Proteins

Identifiers

PMID19434080
PMCPMC2820605

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.